The document discusses the shift in healthcare towards outcome-based payment models where pharmaceutical companies are paid based on patient outcomes rather than simply selling pills. It notes that non-adherence to medication is a major issue, with 50% of medicines not taken as prescribed, representing a 36% loss in potential sales. The document then introduces a proposed portable medication adherence device that would keep track of medication intake, assess adherence, and integrate with mobile apps and payers to provide data on outcomes in order to better serve patients and payers. It acknowledges challenges startups face compared to large companies and stresses the importance of innovation, both internal and through external partnerships.